Editor's Pick
The method could be used to sequence DNA molecules that fall between short and long reads, but where high throughput and single-base accuracy are required.
The technology has been licensed by MGeneRx, which plans to commercialize it in the US first, then expand to low- and middle-income countries.
Developed by researchers at the National Institutes of Health, the method could reduce the cost of sample prep by a factor of eight.
With a throughput of 150,000 tests per day on a single system, the workflow is now in use in a so-called megalab in the UK.
The company said the results highlight precision oncology implementation challenges and its test's ability to help overcome these issues.
Sep 9, 2021
Aug 19, 2021
Aug 18, 2021
Aug 18, 2021
Aug 17, 2021
Aug 5, 2021
Jul 29, 2021
Jul 28, 2021
Jul 27, 2021
Jul 22, 2021